Ocular inflammation therapeutic (Tibet Rhodiola Pharmaceutical)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameOcular inflammation therapeutic (Tibet Rhodiola Pharmaceutical)
Drug Alias NameRecombinant human interleukin-1 receptor antagonist protein - Tibet Rhodiola PharmaceuticalIL-1-Ra
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A